2006The Chinese Journal of Modern Applied PharmacyRequires access

Effects of rosiglitazone on the expresstion of α-SMA in proximal tubular epithelial cells in type2 diabetic rats

SU Sheng-ou

Open publisher page 0 citations

Abstract

OBJECTIVE To study the effects of rosiglitazone on the expresstion of α-SMA in proximal tubular epithelial cells in type2 diabetic rats.METHODS Making 2 type diabetic rats mode by given high-sugar and high-fat diets,associating injection of small count streptozotocin(STZ) in abdominal cavity,to observe pathological changes in control,diabetic,and rosiglitazone-treated groups successively,and to detect the expression of α-SMA,in proximal tubular epithelial cells by immunohistochemistry,to detect α-SMA expression by flow cytometry.RESULTS 1 Symptom and sign: the diabetic rats showed the symptoms of polyuria,polydipsia,polyphagia,after injection of STZ 1 to 2 days,as the progression of DN,which became serious.At week 24,the diabetic rats'spirits dispirited,hairs dimmed,the behaviors reduced.But the weights of diabetic rats did not low in the whole progression,the rosiglitazone-treated group was similar with the diabetic group in symptom and sign.2 Biochemical examination: FBG,Ins,TG,TC,Uaer of diabetic group increased more significantly,than normal group,Ccr decreased(P0.05).Comparing with diabetic group,Ins,TC,Uaer,in rosiglitazone-treated group,decreased,but the FBG,TG,Ccr did not significantly decreased(P0.05).3 Pathological changes: Light microscopy: comparing with normal group,in diabetic group,a few of the tubules atrophy or dilataltion and the tubular epithelia cells were swelling,and light fatty degeneration in the cytoplasm.In rosiglitazone-treated group,pathological changes lightened,between the normal group and diabetic group.4 Immunohistochemical staining: comparing with normal group,in the diabetic rats the expression of α-SMA enhanced.In rosiglitazone group,expression of α-SMA was in the range of the normal group and the diabetic group.The detections of α-SMA by flow cell technic were coincidence with results of immunohistochemistry.CONCLUSION Rosiglitazone not only can relieve the insulin resistance,correct the disturbance of lipo-metabolism,decrease the Uaer,but also can relieve the expression of α-SMA in tubular epithelial cells,delay the interstitial fibrosis,to protecting kidney.

About this research paper

What this paper is about

OBJECTIVE To study the effects of rosiglitazone on the expresstion of α-SMA in proximal tubular epithelial cells in type2 diabetic rats.METHODS Making 2 type diabetic rats mode by given high-sugar and high-fat diets,associating injection of small count streptozotocin(STZ) in abdominal cavity,to observe pathological changes in control,diabetic,and rosiglitazone-treated groups successively,and to detect the expression of α-SMA,in proximal tubular epithelial cells by immunohistochemistry,to detect α-SMA expression by flow cytometry.RESULTS 1 Symptom and sign: the diabetic rats showed the symptoms of polyuria,polydipsia,polyphagia,after injection of STZ 1 to 2 days,as the progression of DN,which became serious.At week 24,the diabetic rats'spirits dispirited,hairs dimmed,the behaviors reduced.But the weights of diabetic rats did not low in the whole progression,the rosiglitazone-treated group was similar with the diabetic group in symptom and sign.2 Biochemical examination: FBG,Ins,TG,TC,Uaer of diabetic group increased more significantly,than normal group,Ccr decreased(P0.05).Comparing with diabetic group,Ins,TC,Uaer,in rosiglitazone-treated group,decreased,but the FBG,TG,Ccr did not significantly decreased(P0.05).3 Pathological changes: Light microscopy: comparing with normal group,in diabetic group,a few of the tubules atrophy or dilataltion and the tubular epithelia cells were swelling,and light fatty degeneration in the cytoplasm.In rosiglitazone-treated group,pathological changes lightened,between the normal group and diabetic group.4 Immunohistochemical staining: comparing with normal group,in the diabetic rats the expression of α-SMA enhanced.In rosiglitazone group,expression of α-SMA was in the range of the normal group and the diabetic group.The detections of α-SMA by flow cell technic were coincidence with results of immunohistochemistry.CONCLUSION Rosiglitazone not only can relieve the insulin resistance,correct the disturbance of lipo-metabolism,decrease the Uaer,but also can relieve the expression of α-SMA in tubular epithelial cells,delay the interstitial fibrosis,to protecting kidney.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study the effects of rosiglitazone on the expresstion of α-SMA in proximal tubular epithelial cells in type2 diabetic rats.METHODS Making 2 type diabetic rats mode by given high-sugar and high-fat diets,associating injection of small count streptozotocin(STZ) in abdominal cavity,to observe pathological changes in control,diabetic,and rosiglitazone-treated groups successively,and to detect the expression of α-SMA,in proximal tubular epithelial cells by immunohistochemistry,to detect α-SMA expression by flow cytometry.RESULTS 1 Symptom and sign: the diabetic rats showed the symptoms of polyuria,polydipsia,polyphagia,after injection of STZ 1 to 2 days,as the progression of DN,which became serious.At week 24,the diabetic rats'spirits dispirited,hairs dimmed,the behaviors reduced.But the weights of diabetic rats did not low in the whole progression,the rosiglitazone-treated group was similar with the diabetic group in symptom and sign.2 Biochemical examination: FBG,Ins,TG,TC,Uaer of diabetic group increased more significantly,than normal group,Ccr decreased(P0.05).Comparing with diabetic group,Ins,TC,Uaer,in rosiglitazone-treated group,decreased,but the FBG,TG,Ccr did not significantly decreased(P0.05).3 Pathological changes: Light microscopy: comparing with normal group,in diabetic group,a few of the tubules atrophy or dilataltion and the tubular epithelia cells were swelling,and light fatty degeneration in the cytoplasm.In rosiglitazone-treated group,pathological changes lightened,between the normal group and diabetic group.4 Immunohistochemical staining: comparing with normal group,in the diabetic rats the expression of α-SMA enhanced.In rosiglitazone group,expression of α-SMA was in the range of the normal group and the diabetic group.The detections of α-SMA by flow cell technic were coincidence with results of immunohistochemistry.CONCLUSION Rosiglitazone not only can relieve the insulin resistance,correct the disturbance of lipo-metabolism,decrease the Uaer,but also can relieve the expression of α-SMA in tubular epithelial cells,delay the interstitial fibrosis,to protecting kidney.

Key concepts: Rosiglitazone, Polydipsia, Endocrinology, Internal medicine, Polyuria, Streptozotocin, Medicine, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of rosiglitazone on the expresstion of α-SMA in proximal tubular epithelial cells in type2 diabetic rats — Research Paper | ScholarLens